Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats.

about

Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats.

Item

http://www.wikidata.org/entity/Q38679383

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacokinetics and tissue di ...... ry metabolite H152/81 in rats.

@en

type

Item

label

Pharmacokinetics and tissue di ...... ry metabolite H152/81 in rats.

@en

prefLabel

Pharmacokinetics and tissue di ...... ry metabolite H152/81 in rats.

@en

P1476

Pharmacokinetics and tissue di ...... ary metabolite H152/81 in rats

@en

P2093

Lanting Zhao

http://www.w3.org/2001/XMLSchema#string

Luning Sun

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Tengfei Li

http://www.w3.org/2001/XMLSchema#string

Wen Yang

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort.

Clevidipine: a review of its use in the management of acute hypertension.

Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.

Bioavailability, tissue distribution, and excretion characteristics of the novel carbonic anhydrase inhibitor tolsultazolamide in rats.

High lipophilicity of perfluoroalkyl carboxylate and sulfonate: implications for their membrane permeability.

Resistant hypertension: an overview of evaluation and treatment.

Clevidipine for the treatment of severe hypertension in adults.

A 15 years study of the causes of death among elderly hypertensive patients in a hospital-based sample of China.

Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.

Body mass index, exercise capacity, and mortality risk in male veterans with hypertension.

P31

scholarly article

P356

10.1002/BMC.4048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Li Ding

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28707762

http://www.w3.org/2001/XMLSchema#string